Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

(2019) Tiziano Barbui et al.   LEUKEMIA

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

(2019) Emanuela Sant'Antonio et al.   AMERICAN JOURNAL OF HEMATOLOGY

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms

(2018) Malin Hultcrantz et al.   ANNALS OF INTERNAL MEDICINE

Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients

(2018) Anna Ravn Landtblom et al.   LEUKEMIA

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients

(2016) V De Stefano et al.   Blood Cancer Journal

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis

(2015) Walter Ageno et al.   JAMA Internal Medicine

Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

(2012) T. Barbui et al.   BLOOD

Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study

(2012) Malin Hultcrantz et al.   JOURNAL OF CLINICAL ONCOLOGY

Age-related differences in disease characteristics and clinical outcomes in polycythemia vera

(2012) Brady L. Stein et al.   LEUKEMIA & LYMPHOMA

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

(2012) Roberto Marchioli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms

(2011) J. HOEKSTRA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

(2010) A. Alvarez-Larran et al.   BLOOD

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

(2008) J.-J. Kiladjian et al.   BLOOD